Business Description
Aceso Life Science Group Ltd
NAICS : 561910
ISIN : KYG4289B1106
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.19 | |||||
Equity-to-Asset | 0.18 | |||||
Debt-to-Equity | 2.44 | |||||
Debt-to-EBITDA | -3.09 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -1.59 | |||||
Beneish M-Score | -2.89 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -14.2 | |||||
3-Year EBITDA Growth Rate | -105.7 | |||||
3-Year Book Growth Rate | -28.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 67.37 | |||||
9-Day RSI | 55.48 | |||||
14-Day RSI | 48.19 | |||||
6-1 Month Momentum % | -58.78 | |||||
12-1 Month Momentum % | -47.06 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.42 | |||||
Quick Ratio | 0.42 | |||||
Cash Ratio | 0.18 | |||||
Days Inventory | 371.64 | |||||
Days Sales Outstanding | 299.28 | |||||
Days Payable | 19.91 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.1 | |||||
Shareholder Yield % | 64.67 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 50.89 | |||||
Operating Margin % | -11.61 | |||||
Net Margin % | -175 | |||||
FCF Margin % | -35.71 | |||||
ROE % | -39.32 | |||||
ROA % | -8.13 | |||||
ROIC % | -0.45 | |||||
ROC (Joel Greenblatt) % | -157.76 | |||||
ROCE % | -23.99 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.71 | |||||
PB Ratio | 0.49 | |||||
Price-to-Tangible-Book | 0.59 | |||||
EV-to-EBIT | -3.11 | |||||
EV-to-EBITDA | -3.11 | |||||
EV-to-Revenue | 8.76 | |||||
EV-to-FCF | -24.52 | |||||
Price-to-Projected-FCF | 0.76 | |||||
Price-to-Median-PS-Value | 0.38 | |||||
Earnings Yield (Greenblatt) % | -32.15 | |||||
FCF Yield % | -20.45 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Aceso Life Science Group Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 224 | ||
EPS (TTM) (HK$) | -0.054 | ||
Beta | -0.08 | ||
Volatility % | 62.21 | ||
14-Day RSI | 48.19 | ||
14-Day ATR (HK$) | 0.003003 | ||
20-Day SMA (HK$) | 0.0517 | ||
12-1 Month Momentum % | -47.06 | ||
52-Week Range (HK$) | 0.044 - 0.185 | ||
Shares Outstanding (Mil) | 7,381.78 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Aceso Life Science Group Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Aceso Life Science Group Ltd Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
Aceso Life Science Group Ltd Frequently Asked Questions
What is Aceso Life Science Group Ltd(HKSE:00474)'s stock price today?
When is next earnings date of Aceso Life Science Group Ltd(HKSE:00474)?
Does Aceso Life Science Group Ltd(HKSE:00474) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |